Gary Herman
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Oncology top 5%
- Peptidase Inhibition and Analysis
Papers in
-
- Diabetes Treatment and Management 25
- Oncology 10
- Peptidase Inhibition and Analysis 9
- Co-authors
- John A. Wagner (20 shared papers)Arthur Bergman (18 shared papers)Bingming Yi (6 shared papers)Karen Snyder (4 shared papers)Keith Gottesdiener (7 shared papers)Kenneth C. Lasseter (9 shared papers)Wesley Tanaka (3 shared papers)Michael Tanen (3 shared papers)
- Journals
- The Journal of Clinical Pharmacology (10 papers)Clinical Pharmacology & Therapeutics (5 papers)Journal of Allergy and Clinical Immunology (3 papers)Open Forum Infectious Diseases (3 papers)Current Medical Research and Opinion (3 papers)
- Partner nations
- United StatesUnited KingdomBelgium
In The Last Decade
Gary Herman
55 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 111
- Endocrinology, Diabetes and Metabolism 1.7k
- Oncology 504
- Pharmacology 271
- Cellular and Molecular Neuroscience 267
- Surgery 540
Countries citing papers authored by Gary Herman
This map shows the geographic impact of Gary Herman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Herman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Herman more than expected).
Fields of papers citing papers by Gary Herman
This network shows the impact of papers produced by Gary Herman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Herman. The network helps show where Gary Herman may publish in the future.
Co-authors
The 25 scholars most cited alongside Gary Herman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 418 | |
| 2 | 2006 | 220 | |
| 3 | 2008 | 183 | |
| 4 | 2007 | 152 | |
| 5 | 2006 | 147 | |
| 6 | 2007 | 139 | |
| 7 | 2007 | 135 | |
| 8 | 2007 | 127 | |
| 9 | 1994 | 81 | |
| 10 | 2006 | 77 | |
| 11 | 2007 | 69 | |
| 12 | 2007 | 56 | |
| 13 | 2001 | 54 | |
| 14 | 1998 | 54 | |
| 15 | Effect of moderate hepatic insufficiency on the pharmacokinetics of sitagliptin. | 2009 | 51 |
| 16 | 2008 | 42 | |
| 17 | 2007 | 41 | |
| 18 | 2010 | 39 | |
| 19 | 2008 | 39 | |
| 20 | 2020 | 38 |
About Gary Herman
Gary Herman is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology, Surgery, Molecular Biology and Cell Biology, having authored 59 papers that have together received 2.7k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (25 papers), Peptidase Inhibition and Analysis (9 papers), Cellular transport and secretion (6 papers), Pancreatic function and diabetes (5 papers), Blood Pressure and Hypertension Studies (3 papers), Allergic Rhinitis and Sensitization (3 papers), Neuroendocrine Tumor Research Advances (3 papers) and Lipid Membrane Structure and Behavior (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.7k citations), Oncology (504 citations), Pharmacology (271 citations), Cellular and Molecular Neuroscience (267 citations) and Surgery (540 citations). Gary Herman has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include John A. Wagner, Arthur Bergman, Bingming Yi, Karen Snyder, Keith Gottesdiener, Kenneth C. Lasseter, Wesley Tanaka, Michael Tanen, Peter P. Stein and Michael J. Davies. Their work appears in journals such as The Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics, Journal of Allergy and Clinical Immunology, Open Forum Infectious Diseases and Current Medical Research and Opinion.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.